Drug Shortage Report for SATIVEX
| Report ID | 154632 |
| Drug Identification Number | 02266121 |
| Brand name | SATIVEX |
| Common or Proper name | Sativex |
| Company Name | GW PHARMA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | CANNABIDIOL DELTA-9-TETRAHYDROCANNABINOL |
| Strength(s) | 2.5MG 2.7MG |
| Dosage form(s) | SPRAY |
| Route of administration | BUCCAL BUCCAL |
| Packaging size | 3 |
| ATC code | N02BG |
| ATC description | OTHER ANALGESICS AND ANTIPYRETICS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2022-03-09 |
| Estimated end date | 2022-03-18 |
| Actual end date | 2022-03-18 |
| Shortage status | Resolved |
| Updated date | 2022-03-19 |
| Company comments | For all inquiries please contact Bayer Medical Information on 1-800-265-7382 or email: canada.medinfo@bayer.com |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | VISION PARK HISTON, CAMBRIDGE, CAMBRIDGESHIRE UNITED KINGDOM CB2 9BZ |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2022-02-09 | English | Compare |
| v2 | 2022-02-09 | English | Compare |
| v3 | 2022-02-09 | French | Compare |
| v4 | 2022-02-09 | French | Compare |
| v5 | 2022-02-10 | English | Compare |
| v6 | 2022-02-11 | English | Compare |
| v7 | 2022-02-11 | French | Compare |
| v8 | 2022-02-11 | English | Compare |
| v9 | 2022-02-11 | French | Compare |
| v10 | 2022-02-22 | English | Compare |
| v11 | 2022-02-22 | French | Compare |
| v12 | 2022-02-28 | English | Compare |
| v13 | 2022-02-28 | French | Compare |
| v14 | 2022-02-28 | English | Compare |
| v15 | 2022-02-28 | French | Compare |
| v16 | 2022-03-03 | English | Compare |
| v17 | 2022-03-03 | English | Compare |
| v18 | 2022-03-03 | French | Compare |
| v19 | 2022-03-05 | English | Compare |
| v20 | 2022-03-07 | English | Compare |